A Critical Evaluation of Neuroprotective and Neurodegenerative MicroRNAs in Alzheimer’s Disease

Currently, 5.4 million Americans suffer from AD, and these numbers are expected to increase up to 16 million by 2050. Despite tremendous research efforts, we still do not have drugs or agents that can delay, or prevent AD and its progression, and we still do not have early detectable biomarkers for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biochem Biophys Res Commun
Main Authors: Reddy, P. Hemachandra, Tonk, Sahil, Kumar, Subodh, Vijayan, Murali, Kandimalla, Ramesh, Kuruva, Chandra Sekhar, Reddy, Arubala P.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343756/
https://ncbi.nlm.nih.gov/pubmed/27524239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2016.08.067
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares